Scibase AB

SCIB · Nasdaq Stockholm · Healthcare

14.85SEK −0.3%last day

Price as of 2 October 2026

The price over the past year, with dividends: −53.1%

Performance

1 month

−13.2%

1 year

−53.1%

3 years, per year

−45.6%

5 years, per year

−47.9%

Largest fall, 3 years

−96.4%

Below the peak now

−99.4%

Volatility, 1 year

74.4%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

4.8

Dividend yield

0.0%

Return on equity

−322.7%

Net margin

−186.1%

Market value

15 m USD

Quality, value and trend

Where Scibase stands against every Nordic stock today. 100 is best.

Quality56

Profitability and a sound balance sheet over time. Better than 56% of Nordic stocks.

Value9

The price measured against earnings, assets and cash flow. Better than 9% of Nordic stocks.

Trend3

The price development over the past year. Better than 3% of Nordic stocks.

Combined6

Quality, value and trend together. Better than 6% of Nordic stocks.

About Scibase

Scibase AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 50 employees.

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration with Mayo Clinic on pigmented lesion digital workflows with AI-driven Nevisense.SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis